Sernova Biotherapeutics (TSX:SVA) Change In Inventory : C$0.00 Mil (TTM As of Jan. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics Change In Inventory?

Sernova Biotherapeutics's change in inventory for the quarter that ended in Jan. 2025 was C$0.00 Mil. It means Sernova Biotherapeutics's inventory stayed the same from Oct. 2024 to Jan. 2025 .

Sernova Biotherapeutics's change in inventory for the fiscal year that ended in Oct. 2024 was C$0.00 Mil. It means Sernova Biotherapeutics's inventory stayed the same from Oct. 2023 to Oct. 2024 .

Sernova Biotherapeutics's Total Inventories for the quarter that ended in Jan. 2025 was C$0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sernova Biotherapeutics Change In Inventory Historical Data

The historical data trend for Sernova Biotherapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Change In Inventory Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Change In Inventory

Get a 7-Day Free Trial

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Sernova Biotherapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Sernova Biotherapeutics (TSX:SVA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sernova Biotherapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sernova Biotherapeutics's Inventory Turnover for the quarter that ended in Jan. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sernova Biotherapeutics's Inventory to Revenue for the quarter that ended in Jan. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

Sernova Biotherapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (TSX:SVA) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Executives